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Abstract
Aims/hypothesis The present study compares the impact of
endurance- vs resistance-type exercise on subsequent 24 h
blood glucose homeostasis in individuals with impaired
glucose tolerance (IGT) and type 2 diabetes.
Methods Fifteen individuals with IGT, 15 type 2 diabetic
patients treated with exogenous insulin (INS), and 15 type 2
diabetic patients treated with oral glucose-lowering medi-
cation (OGLM) participated in a randomised crossover
experiment. Participants were studied on three occasions for
3 days under strict dietary standardisation, but otherwise
free-living conditions. Blood glucose homeostasis was
assessed by ambulatory continuous glucose monitoring
over the 24 h period following a 45 min session of
resistance-type exercise (75% one repetition maximum),
endurance-type exercise (50% maximum workload capacity)
or no exercise at all.
Results Average 24 h blood glucose concentrations were
reduced from 7.4±0.2, 9.6±0.5 and 9.2±0.7 mmol/l during
the control experiment to 6.9±0.2, 8.6±0.4 and 8.1±0.5
mmol/l (resistance-type exercise) and 6.8±0.2, 8.6±0.5 and
8.5±0.5 mmol/l (endurance-type exercise) over the 24 h
period following a single bout of exercise in the IGT,
OGLM and INS groups, respectively (p<0.001 for both
treatments). The prevalence of hyperglycaemia (blood
glucose >10 mmol/l) was reduced by 35±7 and 33±11%
over the 24 h period following a single session of resistance-
and endurance-type exercise, respectively (p<0.001 for
both treatments).
Conclusions/interpretation A single session of resistance-
or endurance-type exercise substantially reduces the
prevalence of hyperglycaemia during the subsequent
24 h period in individuals with IGT, and in insulin-treated
and non-insulin-treated type 2 diabetic patients. Both
resistance- and endurance-type exercise can be integrated in
exercise intervention programmes designed to improve
glycaemic control.
Trial registration: Clinicaltrials.gov NCT00945165
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ACSM American College of Sports Medicine
IGT Impaired glucose tolerance
INS Exogenous insulin
OGIS Oral glucose insulin sensitivity (index)
OGLM Oral glucose-lowering medication
PAL Physical activity level
1RM One repetition maximum
Wmax Maximum workload capacity
Introduction
Over the last 15 years, postprandial hyperglycaemia has
been increasingly recognised as a strong and independent
risk factor for the development of cardiovascular compli-
cations in type 2 diabetic patients [1]. Nevertheless,
postprandial hyperglycaemia is highly prevalent throughout
the day in type 2 diabetic patients, even in patients with
apparently good glycaemic control according to their
HbA1c levels [2, 3]. Therefore, more effective treatment
strategies should be defined to reduce the prevalence of
postprandial hyperglycaemia.
Structured exercise programmes have been shown to
improve long-term glycaemic control (i.e. HbA1c) in type 2
diabetic patients [4, 5]. The glucoregulatory effects of
exercise result from an increased insulin sensitivity, which
has been shown to persist for up to 48 h following a single
bout of exercise [6–8]. In accordance, we have recently
shown that a single bout of exercise can strongly reduce the
prevalence of hyperglycaemia throughout the day [9].
Consequently, the benefits of exercise on long-term
glycaemic control can be largely ascribed to the cumulative
glucoregulatory effects of each successive bout of exercise
[6, 7]. To optimise the impact of exercise as an effective
strategy to improve glycaemic control, more information is
needed on the impact of the various exercise modalities
(e.g. type, intensity, duration, frequency and timing of
exercise) on daily blood glucose homeostasis.
From a historical perspective, endurance exercise has
always been the type of exercise implemented in diabetes
intervention programmes. This is attributable to the
successful application of endurance-type exercise training
as a means to reduce fat mass and improve weight
maintenance [10, 11]. However, endurance-type exercise
is not always the most applicable type of exercise as many
type 2 diabetic patients suffer from muscle weakness,
cardiovascular comorbidities, polyneuropathy and reduced
exercise tolerance [12–14], which generally lower the
feasibility of strict endurance-type exercise programmes.
Furthermore, the loss of skeletal muscle mass, strength and
function in the ageing diabetes population forms a major
therapeutic target that requires the implementation of
resistance-type exercise [12, 14, 15]. This has resulted in
the inclusion of a statement in the current ADA/American
College of Sports Medicine (ACSM) exercise guidelines
for type 2 diabetic patients that ‘in addition to aerobic
training, persons with type 2 diabetes should undertake
moderate to vigorous resistance training at least 2–3 days
per week’ [13]. However, this 2010 joint position statement
also recognises that the impact of a single bout of resistance-
type exercise on glycaemic control in type 2 diabetic patients
remains to be established. As it is presently unclear whether
resistance-type exercise can also modulate glycaemic control
throughout the subsequent day, healthcare professionals have
been rather restrictive in the implementation of resistance-
type exercise in diabetes intervention programmes.
To provide support for the current recommendations
concerning optimal exercise prescription in type 2 diabetes
treatment, this study investigates the impact of both
resistance- and endurance-type exercise on daily blood
glucose homeostasis. Therefore, we assessed 24 h glycaemic
control following a single bout of resistance- as well as
endurance-type exercise in individuals with impaired glucose
tolerance (IGT), type 2 diabetic patients treated with oral
blood-glucose-lowering medication (OGLM), and type 2
diabetic patients treated with exogenous insulin (INS).
Methods
Participants Fifteen men with IGT and 30 men with type 2
diabetes were recruited to participate. All patients with type 2
diabetes had been treated with stable OGLM only (n=15) or
insulin (n=15) for at least 3 months before being recruited.
Exclusion criteria were renal failure, liver disease, morbid
obesity (BMI >40 kg/m2), hypertension (>160 mmHg
systolic and/or >100 mmHg diastolic), and a history of
severe cardiovascular problems (myocardial infarction in the
last year or stroke). All volunteers were informed about the
nature and the risks of the experimental procedures before
their written informed consent was obtained. The Medical
Ethical Committee of the Maastricht University Medical
Centre+ approved all clinical experiments.
Screening and pretesting All participants, except for the
INS group, underwent an OGTT. In the OGLM group,
blood-glucose-lowering medication was withheld 2 days
prior to the OGTT. After an overnight fast, participants
arrived at the laboratory at 08:00 hours by car or public
transportation. A fasting blood sample was obtained, after
which an OGTT was performed to determine IGT or type 2
diabetes according to ADA criteria [16]. Maximum strength
(one repetition maximum [1RM]) was determined for the
leg press and leg extension as described previously [17].
Participants performed an incremental cycling test to
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determine their maximum workload capacity (Wmax). After
a 2.5 min warm-up at 0.75 W/kg body weight, workload
was increased with 0.25 W/kg body weight every 2 min
until exhaustion. Cardiac function was monitored using a
12 lead electrocardiogram.
Blood sample analysis During the screening, venous blood
samples (10 ml) were collected in EDTA-containing tubes
and centrifuged at 1,000 g and 4°C for 10 min. Aliquots of
plasma were immediately frozen in liquid nitrogen and
stored at −80°C until analyses. Glucose concentrations
(Roche, Basel, Switzerland), NEFA concentrations (Wako
Chemicals, Neuss, Germany), triacylglycerol concentra-
tions (ABX Diagnostics, Montpellier, France) and total
cholesterol concentrations (ABX Diagnostics) were deter-
mined enzymatically with the COBAS FARA semi-
automatic analyzer (Roche). Plasma insulin concentrations
were determined by radioimmunoassay (HI-14K, Linco
Research, St Charles, MI, USA). HbA1c content was
determined in 3 ml venous blood samples by high-
performance liquid chromatography (Bio-Rad Diamat,
Munich, Germany). Venous plasma glucose and insulin
concentrations obtained during the OGTT were used to
assess insulin sensitivity with the oral glucose insulin
sensitivity (OGIS) index [18].
Study design All participants participated in a randomised
crossover experiment, consisting of three intervention
periods separated by at least 4 days. Each intervention
period consisted of 3 days during which the impact of a
single session of exercise on subsequent 24 h blood glucose
homeostasis was assessed under standardised dietary, but
otherwise free living, conditions (Fig. 1). Periods were
identical with the exception of the type of exercise that was
performed (no exercise, resistance- or endurance-type
exercise). On day 1 of each intervention period, participants
arrived at the laboratory in the afternoon and received a
short training in the use of the capillary blood sampling
method (Glucocard X Meter, Arkray, Kyoto, Japan).
Subsequently, a continuous glucose monitoring device
(GlucoDay S; A. Menarini Diagnostics, Florence, Italy)
was attached, after which participants returned home. On
day 2, participants arrived at the laboratory at 08:30 hours
for breakfast. After a resting period, the exercise or control
intervention was performed from 11:00 to 11.45 hours.
After lunch at 12:30 hours, participants were free to go
home and resume their normal daily activities. On day 3,
participants arrived at the laboratory in the afternoon for
removal of the continuous-glucose-monitoring device.
Exercise protocol The endurance-type exercise session
consisted of 45 min of continuous cycling, performed
on a cycle ergometer (Lode Excalibur, Groningen, the
Netherlands). Based on earlier work [9], continuous
cycling was performed at a moderate workload intensity
(50% Wmax). The 45 min resistance-type exercise session
started with two upper-body resistance exercise machines
(lateral pull down and chest press). A warming-up set was
performed at a workload of 20% bodyweight, followed by
three sets of ten repetitions at 40% bodyweight. Thereafter,
the resistance exercise session targeted the legs (i.e. leg
press, leg extension). Based on earlier reports [17, 19], five
sets of ten repetitions were performed at 55%, 65%, 75%,
75% and 75% of the participants’ individual 1RM,
respectively. A resting period of approximately 2 min was
allowed between sets. During the control (no exercise)
experiment participants were seated for 45 min in a chair
next to the cycle ergometer.
Diet and physical activity All participants were asked to
maintain habitual physical activity patterns throughout the
experimental period, but to refrain from exhaustive physical
Day 1 Day 2 Day 3
24 h analysis period
00:00 06:00 12:00 18:00
Time of day (hours)
00:0018:00 06:00 12:00
Fig. 1 Schematic overview of an experimental period. On day 1,
participants reported to the laboratory in the afternoon for insertion of
the continuous-glucose-monitoring device (downward arrow with
horizontal lines), after which they were free to go home and resume
their normal daily activities. During an experimental period, participants
consumed a strictly standardised diet with main meals (knife and fork) at
08:30, 12:30 and 18:00 hours. On day 2, participants arrived at the
laboratory at 08:30 hours for breakfast. After a resting period, the
resistance-type exercise, endurance-type exercise or control (no exercise)
intervention (running symbol) was performed from 11:00 to 11:45 hours.
After lunch, participants were free to go home and resume their normal
daily activities. On day 3, participants arrived at the laboratory in the
afternoon for removal of the continuous-glucose-monitoring device
(upward arrow with horizontal lines). The glycaemic profiles obtained
during the 24 h period following exercise (from 12:00 to 12:00 hours)
were used for analysis
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labour and exercise training for 2 days prior to and during
the intervention period. During the intervention period,
habitual physical activity was assessed using a validated
triaxial accelerometer (Philips DirectLife, Eindhoven, the
Netherlands) [20], worn in a belt around the waist.
Accelerometer data obtained during the 24 h period
following exercise were used to calculate physical activity
level (PAL) applying the equation by Bonomi et al. [20].
During each intervention period, participants were
provided with a healthy standardised diet, composed
according to the ADA dietary recommendations for type 2
diabetes [21]. The diet consisted of three meals and three
snacks per day, distributed in pre-weighed packages and
ingested at pre-determined time-points to ensure a fully
standardised diet during the ∼48 h test periods. The diet
provided 10.4±0.1 MJ/day consisting of 57% of energy
from carbohydrate, 13% of energy from protein and 30% of
energy from fat. The diet was designed to meet the energy
requirements as calculated with the Harris–Benedict equation
(1918) multiplied by a PAL of 1.4.
Medication Patients’ blood-glucose-lowering medications
are shown in Table 1. Treatment with OGLM and/or insulin
was continued as normal throughout the entire experimental
period. Insulin-treated diabetic patients were explicitly
asked not to deviate from their habitual insulin treatment
schemes when exercise was performed. None of the
volunteers in the IGT group was using any medication
known to interfere with glucose metabolism.
Statistics and data analysis The acquired data from the
continuous glucose monitor were downloaded to a personal
computer with GlucoDay software (V3.2.2). Values
reported by the continuous-glucose-monitoring device were
converted into glucose values using the self-monitored
capillary blood glucose values. The glycaemic profiles
during the 24 h period following exercise (from 12:00 to
12:00 hours) were used to determine average glucose
concentrations, the prevalence of hyperglycaemia (glucose
concentrations >10 mmol/l), and the prevalence of hypogly-
caemia (glucose concentrations <3.9 mmol/l). In addition,
these variables were also calculated over four different periods
within the 24 h time frame: the afternoon (12:00–18:00 hours),
evening (18:00–00:00 hours), nocturnal (00:00–06:00 hours)
and morning (06:00–12:00 hours) periods.
Intervention effects were assessed by one-way repeated
measures ANOVA,with intervention, group and intervention×
group as within-subject factor, between-subject factor and
interaction, respectively. When applicable, pairwise compar-
isons with Bonferroni correction were applied to locate
differences between interventions, and Scheffé’s post hoc test
was applied to locate differences between groups. Statistical
comparisons were considered significant when p values
were <0.05. All statistical calculations were performed using
the SPSS 15.0.1.1 software package. Unless otherwise
specified, reported results represent means±SEM.
Results
Participants Participants’ characteristics are shown in
Table 1. Groups were comparable with respect to age and
BMI. Type 2 diabetic patients in the OGLM group had been
diagnosed with diabetes for 6.5±1.0 years, whereas patients
in the INS group had been diagnosed for 13.5±2.2 years
(p<0.05) and had been treated with insulin for 5.1±1.2
years. HbA1c content was similar in the OGLM and
INS groups (7.5±0.2 and 7.6±0.3%, respectively), but
lower in the IGT group (6.1±0.1%; p<0.05). Fasting
plasma glucose concentrations were similar in the OGLM
and INS groups (9.8±0.6 and 8.4±0.6 mmol/l, respectively),
but lower in the IGT group (6.3±0.2 mmol/l; p<0.05).
Fasting plasma insulin concentrations tended to be higher in
the IGT group (174±24 pmol/l) when compared with the
OGLM group (114±17 pmol/l; p=0.053), and 2 h post-
challenge plasma insulin concentrations were threefold
higher in the IGT group (893±179 pmol/l) compared with
the OGLM group (278±55 pmol/l; p<0.05). No significant
differences were observed in the OGIS index between
the IGT and OGLM groups (289±18 and 296±17
ml min−1 m−2, respectively; p=0.756). Furthermore,
no differences in exercise performance (1RM andWmax) were
observed when comparing the subpopulations included.
Experimental periods All 45 participants successfully
completed each of the three experimental treatments
(resistance-type exercise, endurance-type exercise and no
exercise). Participants were compliant with respect to
their medication and standardised diet, as verified by dietary
records. Both dosing and timing of blood-glucose-lowering
medication were identical during the three experimental
periods, since these factors were registered during the first
experimental period and replicated during second and
third period. During the experimental periods, insulin-
treated type 2 diabetic patients were using 0.66±0.07 U
insulin (kg body weight)−1day−1.
Habitual physical activity Overall, habitual PALs over the
24 h following a single session of both resistance- and
endurance-type exercise (PAL 1.69±0.13 and 1.69±0.12)
did not differ from the control experiment (1.69±0.13;
p=0.989). No differences in PAL were observed between
groups (between-group effect p=0.389).
24 h glucose concentrations During the control experiment,
average 24 h blood glucose concentrations were 7.4±0.2,
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9.6±0.5 and 9.2±0.7 mmol/l in the IGT, OGLM and INS
groups, respectively (Fig. 2a). Over the 24 h following a
single bout of resistance-type exercise, average blood
glucose concentrations were lowered to 6.9±0.2, 8.6±0.4
and 8.1±0.5 mmol/l in the IGT, OGLM and INS groups,
respectively (p<0.001). Comparable effects were observed
over the 24 h following endurance-type exercise, with
average 24 h blood glucose concentrations being lowered to
6.8±0.2, 8.6±0.5 and 8.5±0.5 mmol/l, respectively
(p<0.001). No differences were observed between the
blood-glucose-lowering properties of resistance- and
endurance-type exercise (p=1.00). There was no exercise×
group interaction (p=0.473), indicating a similar effective-
ness of both types of exercise in all subgroups. Independent
of exercise treatments, a between-group effect was observed
for average 24 h blood glucose concentrations (p=0.016),
indicating lower glucose concentrations in the IGT group
when compared with both diabetic groups (Fig. 2a).
Prevalence of hyperglycaemia Despite the continued use of
glucose-lowering medication and consumption of a healthy
diet, participants experienced excessive hyperglycaemia
throughout a considerable part of the day. In fact, hyper-
glycaemia was prevalent for as much as 2:11±0:37, 9:01±1:39
Table 1 Participants’ characteristics
Group
Characteristic IGT (n=15) OGLM (n=15) INS (n=15) p value
Age (years) 61±2 60±1 61±1 0.860
Time since diagnosis of type 2 diabetes (years) NA 6.5±1.0 13.5±2.2* 0.008
Time on insulin therapy (years) NA NA 5.1±1.2 NA
BMI (kg/m2) 31.7±1.1 29.7±0.8 29.7±1.1 0.210
HbA1c (%) 6.1±0.1 7.5±0.2
† 7.6±0.3† <0.001
HbA1c (mmol/mol) 43±1 58±3
† 60±3† <0.001
Fasting plasma glucose (mmol/l) 6.3±0.2 9.8±0.6† 8.4±0.6† <0.001
2 h post-challenge plasma glucose (mmol/l) 9.2±0.2 16.7±1.1† NA <0.001
Fasting plasma insulin (pmol/l) 174±24 114±17 NA 0.053
2 h post-challenge plasma insulin (pmol/l) 893±179 278±55† NA <0.001
OGIS index (ml min−1 m−2) 289±18 296±17 NA 0.756
Total cholesterol (mmol/l) 5.41±0.29 4.94±0.23 4.35±0.21† 0.009
Fasting plasma TG (mmol/l) 2.00±0.24 1.61±0.20 1.58±0.20 0.275
Fasting plasma NEFA (μmol/l) 605±56 573±62 471±47 0.154
Systolic blood pressure (mmHg) 140±5 140±4 139±3 0.994
Diastolic blood pressure (mmHg) 78±3 80±1 78±2 0.817
Wmax (W/kg body weight) 2.1±0.2 1.9±0.1 1.8±0.1 0.229
Leg press 1RM (kg) 200±10 199±8 209±12 0.347
Leg extension 1RM (kg) 86±4 97±4 85±6 0.174
OGLM (n) 0 15 10 NA
Metformin+SUD and/or TZD (n) 0 6 1 NA
Metformin only (n) 0 8 8 NA
SUD only (n) 0 1 0 NA
TZD only (n) 0 0 1 NA
Insulin treatment (n) 0 0 15 NA
Basal (n) 0 0 2 NA
Biphasic (n) 0 0 4 NA
Multiple (n) 0 0 7 NA
Pump (n) 0 0 2 NA
Insulin dose (U [kg body weight]−1day−1) 0 0 0.66±0.07 NA
Data are expressed as means±SEM or frequencies
In the OGLMgroup, glucose, insulin, andOGIS indexwere determined from anOGTT, performed after 2 days of discontinuation of habitual use of OGLM
Significantly different when compared with the OGLM group (* p<0.05); significantly different when compared with the IGT group († p<0.05)
NA, not applicable; SUD, sulfonylurea; TG, triacylglycerol; TZD, thiazolidinedione
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and 8:16±1:44 h:min (over 24 h) in the IGT, OGLM and INS
groups, respectively. Over the 24 h following a single session
of resistance-type exercise, the prevalence of hyperglycaemia
was reduced to 1:13±0:20, 6:32±1:21 and 5:16±1:27 h:min in
the IGT, OGLM and INS groups, respectively. In a similar
fashion, the prevalence of hyperglycaemia was decreased
over the 24 h period following endurance-type exercise to
1:19±0:33, 6:53±1:46 and 5:21±1:37 h:min in the IGT,
OGLM and INS groups, respectively (Fig. 2b). As such, the
prevalence of hyperglycaemia was reduced by 35±7% and
33±11% over the 24 h following a single session of
resistance- and endurance-type exercise, respectively
(p<0.001 for both exercise treatments). No differences were
observed between the effects of both types of exercise on
hyperglycaemia (p=1.00). The effects of resistance- and
endurance-type exercise on hyperglycaemia were similar
in the subpopulations studied (exercise×group interaction
p=0.169). Independent of exercise treatment, a between-
group effect was observed (p=0.005), indicating a shorter
duration of hyperglycaemic episodes in the IGT group
when compared with both diabetic groups (Fig. 2b).
Prevalence of hypoglycaemia During the control experiment,
the average duration of hypoglycaemia was 0:13±0:05,
0:08±0:05, and 0:39±0:22 h:min per day in the IGT,
OGLM and INS groups, respectively. The prevalence of
hypoglycaemia was comparable over the 24 h following
resistance-type exercise (0:09±0:05, 0:12±0:10 and
0:30±0:13 h:min) and endurance-type exercise (0:19±0:08,
0:24±0:13 and 0:35 h:min) in the IGT, OGLM and INS
groups, respectively. As such, the prevalence of hypoglycae-
mia was not affected by exercise (main effect p=0.602). The
effects of resistance- and endurance-type exercise on
hypoglycaemia did not differ between the studied subpopu-
lations (exercise×group interaction p=0.926). Independent
of exercise treatment, the prevalence of hypoglycaemia
tended to be higher in the INS group when compared with
the IGT and OGLM groups (between-group effect p=0.062).
Glycaemic profile analysis Detailed data on the glucose-
lowering effects of exercise calculated over different time
periods within the 24 h period are provided in Table 2.
Endurance-type exercise induced strong glucoregulatory
effects over the first 6 h following exercise, as both average
glucose levels and the prevalence of hyperglycaemia were
lower during this time period when compared with the
control experiment (Table 2). These glucoregulatory effects
of a single bout of endurance-type exercise were also
observed over the subsequent evening period (6–12 h later),
and the following morning period (18–24 h later; Table 2).
Over the subsequent afternoon and evening following a
single bout of resistance-type exercise, the prevalence of
hyperglycaemia tended to be lower when compared with
the control experiment, but these observations did not reach
statistical significance (p<0.08). Interestingly, in the
resistance-type exercise experiment, average glucose con-
centrations and the prevalence of hyperglycaemia were
significantly reduced during the subsequent nocturnal and
morning periods (12–18 h later and 18–24 h later,
respectively) following exercise (Table 2). Although none
of the participants reported symptomatic hypoglycaemia
during or directly after exercise, endurance-type exercise
induced a slight increase in the prevalence of hypoglycaemia
(blood glucose concentration <3.9 mmol/l) during this time
period (11:00–12:30 hours; Table 2).
Fig. 2 Average glucose concentrations (a) and the prevalence of
hyperglycaemia (glucose concentrations >10 mmol/l) (b) in individuals
with IGT, type 2 diabetic patients using OGLM only, and type 2
diabetic patients using insulin, assessed over the 24 h following no
exercise (control; white bars), resistance-type exercise (black bars) and
endurance-type exercise (hatched bars). Significantly different compared
with the control experiment (*p<0.05); significant group effect
compared with OGLM and INS groups (†p<0.05)
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Table 2 Glycaemic variables calculated over five different time frames during or after exercise in the control (no exercise), resistance-type
exercise and endurance-type exercise experiment
Time frame/variables Control Resistance Endurance p value
Exercise effect Group effect Exercise×group effect
Exercise and immediately following exercise
(11:00–12:30 hours)
Average glucose concentration (mmol/l) 0.173 <0.001§,¶ 0.427
IGT 7.1±0.3 6.9±0.4 7.0±0.4
OGLM 11.7±1.0 11.1±0.9 9.8±0.8
INS 10.8±0.9 10.9±0.9 10.4±1.1
Hyperglycaemia (h:min) 0.074 <0.001§,¶ 0.087
IGT 0:03±0:02 0:05±0:03 0:09±0:04
OGLM 0:51±0:09 0:47±0:08 0:37±0:08
INS 0:52±0:09 0:49±0:08 0:36±0:07
Hypoglycaemia (h:min) 0.036 0.240 0.246
IGT 0:00±0:00 0:04±0:03 0:07±0:04
OGLM 0:00±0:00 0:00±0:00 0:03±0:02
INS 0:00±0:00 0:00±0:01 0:00±0:00
Afternoon period (12:00–18:00 hours)
Average glucose concentration (mmol/l) <0.001† 0.003§,¶ 0.182
IGT 6.7±0.3 6.8±0.2 6.5±0.3
OGLM 9.9±0.8 8.9±0.6 8.1±0.7
INS 9.6±0.8 8.6±0.7 8.0±0.4
Hyperglycaemia (h:min) 0.003† 0.003§,¶ 0.296
IGT 0:22±0:10 0:11±0:04 0:18±0:14
OGLM 2:24±0:31 1:51±0:26 1:23±0:32
INS 2:13±0:13 1:38±0:28 1:17±0:18
Hypoglycaemia (h:min) 0.226 0.814 0.263
IGT 0:08±0:05 0:06±0:04 0:11±0:05
OGLM 0:03±0:03 0:02±0:02 0:18±0:12
INS 0:11±0:06 0:03±0:03 0:03±0:02
Evening period (18:00–00:00 hours)
Average glucose concentration (mmol/l) 0.006*,† 0.045§ 0.288
IGT 7.8±0.5 7.1±0.2 7.1±0.4
OGLM 9.2±0.4 8.9±0.5 9.1±0.6
INS 9.2±0.8 8.2±0.5 7.7±0.7
Hyperglycaemia (h:min) 0.047† 0.036§ 0.231
IGT 0:47±0:21 0:25±0:09 0:27±0:15
OGLM 2:02±0:26 1:48±0:33 2:06±0:36
INS 2:12±0:36 1:25±0:28 0:58±0:27
Hypoglycaemia (h:min) 0.028†,‡ 0.014¶,** 0.063
IGT 0:00±0:00 0:00±0:00 0:00±0:00
OGLM 0:01±0:01 0:00±0:01 0:03±0:02
INS 0:02±0:01 0:02±0:02 0:14±0:06
Nocturnal period (00:00–06:00 hours)
Average glucose concentration (mmol/l) 0.124 0.126 0.301
IGT 6.9±0.3 6.6±0.2 6.4±0.2
OGLM 8.9±0.5 8.3±0.6 8.1±0.6
INS 8.6±1.3 7.3±0.6 8.8±1.5
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Discussion
The present study shows that hyperglycaemia is highly
prevalent throughout the day in individuals with IGT, and
insulin-treated and non-insulin-treated type 2 diabetic
patients. A single session of endurance- or resistance-type
exercise can substantially lower the prevalence of hyper-
glycaemia throughout the subsequent day.
In agreement with previous results [2, 3], we show
that postprandial hyperglycaemia (defined as glucose
levels >10 mmol/l) remains an underestimated problem
in type 2 diabetes. Despite the continued use of blood-
glucose-lowering medication and the provision of a
healthy, well-balanced diet, the insulin- and non-insulin-
treated type 2 diabetic patients were in a hyperglycaemic
state for 34±7% and 38±7% of the 24 h assessment period
(Fig. 2). In addition, this study is the first to assess
glycaemic profiles in prediabetic individuals with IGT.
With hyperglycaemia being present for 9±3% of the day,
the IGT individuals experienced substantially less hyper-
glycaemia throughout the day when compared with the
diabetic patients consuming the same standardised diet
(Fig. 2). Nonetheless, 9±3% of hyperglycaemia is still
threefold higher than the hyperglycaemic episodes that
were previously recorded in overweight, normoglycaemic
men using a comparable standardised diet [3, 22].
Evidently, there is need for effective treatment strategies
in both prediabetic individuals, type 2 diabetic patients
using OGLMs, and long-standing insulin-treated type 2
diabetic patients to reduce the prevalence of hyperglycaemia,
and thereby improve daily glycaemic control.
The effects of long-term exercise training on glycaemic
control (i.e. HbA1c) have been well established [5], and can
be largely ascribed to an improved insulin sensitivity.
Nevertheless, the effects of exercise training on insulin
sensitivity may be lost entirely 6–14 days after cessation of
training [23]. Therefore, improvements in glycaemic con-
trol following exercise training can be largely attributed to
the cumulative effects of transient improvements in glucose
tolerance following each successive bout of exercise, rather
than to the structural adaptive response to prolonged
exercise training [6, 7, 24]. As a consequence, information
on the acute glucoregulatory effects of exercise can be used
to optimise the application of exercise as an effective
Table 2 (continued)
Time frame/variables Control Resistance Endurance p value
Exercise effect Group effect Exercise×group effect
Hyperglycaemia (h:min) 0.016* 0.038 0.370
IGT 0:07±0:03 0:03±0:02 0:03±0:03
OGLM 1:42±0:30 0:57±0:24 1:11±0:29
INS 1:31±0:35 0:49±0:23 1:21±0:39
Hypoglycaemia (h:min) 0.792 0.171 0.804
IGT 0:03±0:03 0:07±0:05 0:02±0:01
OGLM 0:00±0:00 0:02±0:03 0:02±0:01
INS 0:17±0:16 0:11±0:06 0:11±0:05
Morning period (06:00–12:00 hours)
Average glucose concentration (mmol/l) <0.001*,† 0.026§ 0.239
IGT 8.1±0.5 7.5±0.4 7.0±0.4
OGLM 10.2±0.7 8.6±0.4 9.4±0.5
INS 9.5±0.6 8.4±0.5 8.5±0.8
Hyperglycaemia (h:min) <0.001*,† 0.005§ 0.186
IGT 0:52±0:22 0:37±0:16 0:25±0:13
OGLM 3:01±0:30 1:41±0:20 2:11±0:20
INS 2:23±0:27 1:19±0:27 1:35±0:30
Hypoglycaemia (h:min) 0.850 0.288 0.869
IGT 0:06±0:05 0:02±0:02 0:06±0:05
OGLM 0:04±0:04 0:07±0:07 0:01±0:01
INS 0:12±0:09 0:12±0:06 0:08±0:07
Data are expressed as means±SEM
Significance values obtained from post hoc analyses: difference resistance vs control, *p<0.05; difference endurance vs control, † p<0.05;
difference endurance vs resistance, ‡ p<0.05; difference OGLM vs IGT, § p<0.05; difference INS vs IGT, ¶ p<0.05; difference INS vs OGLM,
**p<0.05
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strategy to improve glycaemic control in type 2 diabetic
patients. We have recently shown that a single bout of
continuous endurance-type exercise strongly reduces the
prevalence of hyperglycaemia and lowers blood glucose
concentrations throughout the subsequent 24 h in type 2
diabetic patients [9]. However, as recognised by the current
ADA/ACSM position statement [13], the acute effects of
resistance-type exercise on glycaemic control are less
evident. Although single bouts of endurance- [25, 26] and
resistance-type exercise [17, 27] have been reported to
improve insulin sensitivity for at least 24 h, no studies have
directly assessed the impact of resistance-type exercise on
subsequent glycaemic control. In the present study, continuous
glucosemonitoringwas applied under standardised dietary, but
otherwise free living, conditions to assess the effects of both
resistance- and endurance-type exercise on glycaemic control
throughout the subsequent day. A single bout of resistance-
type exercise reduced the prevalence of hyperglycaemia by as
much as 35±7% during the 24 h post-exercise period when
compared with the control (no exercise) experiment. A similar
33±11% reduction in the prevalence of hyperglycaemia was
observed following a corresponding 45 min bout of
endurance-type exercise (Fig. 2). Previously, the benefits of
resistance-type exercise training on glycaemic control have
often been ascribed to an increase in muscle mass over time
and concomitant expansion of glucose disposal capacity
[12]. However, the present study clearly shows that a single
bout of resistance-type exercise improves glycaemic control
for up to 24 h following exercise, without changes in muscle
mass. These acute improvements in glycaemic control
following resistance-type exercise might be explained by
direct improvements in insulin-dependent [17, 28] and
insulin-independent [29] glucose uptake, similar to the
effects generally observed following endurance-type exercise
[6, 30]. Furthermore, as medication was kept stable, diets
were standardised, and habitual physical activity was
monitored, the effects of both types of exercise occurred
independent from changes in medication, diet and habitual
physical activity. It should be noted, however, that the
observed effects of both types of exercise are only valid for
the exercise intensities applied in the present study. The
moderate-to-high intensity workload applied in both exercise
treatments was perceived as strenuous but feasible for all
participants. Although endurance-type exercise has been
reported to be also effective at lower intensities [9], the
acute glucoregulatory effects of resistance-type exercise at
lower exercise intensities remain to be established.
In the present study, we assessed the impact of both
resistance- and endurance-type exercise on subsequent
glycaemic control in three diabetic subpopulations: predi-
abetic IGT individuals; type 2 diabetic patients treated with
OGLM; and long-standing type 2 diabetic patients using
insulin treatment. Overall, exercise lowered average 24 h
blood glucose concentrations by ∼0.8 mmol/l, while the
prevalence of hyperglycaemia was reduced by ∼34%. Both
resistance- and endurance-type exercise effectively reduced
the prevalence of hyperglycaemia and, as such, improved
glycaemic control in all type 2 diabetic subpopulations.
Interestingly, the blood-glucose-lowering effects of exercise
in the type 2 diabetic patients were observed on top of
pharmacological treatment. In the IGT individuals, exercise
reduced the prevalence of hyperglycaemia, approaching a
level previously observed in normally glucose tolerant
individuals [3]. Whether the high prevalence of hyper-
glycaemia as previously reported in type 1 diabetic patients
[31] can also be effectively reduced by both resistance- and
endurance-type exercise remains to be established.
In addition to hyperglycaemia, we also assessed the
prevalence of hypoglycaemia in the diabetic subpopulations.
Hypoglycaemia is less frequently experienced by type 2
diabetic patients when compared with type 1 diabetic patients
[32]. However, patients with advanced type 2 diabetes are
also at an increased risk of hypoglycaemic episodes [33].
In agreement, the overall prevalence of hypoglycaemia
(defined as blood glucose concentrations <3.9 mmol/l) in
the present study tended to be higher in the long-standing
insulin-treated type 2 diabetic patients when compared with
the IGT and OGLM groups (between-group effect p=0.062),
but the prevalence was still of minor relevance (between 30
and 40 min per day). Though exercise can cause temporary
hypoglycaemia [32], we failed to observe any impact of
resistance- or endurance-type exercise on the daily preva-
lence of hypoglycaemia (main effect p=0.602). This is not
surprising, as we ensured that exercise was performed in the
postprandial state, with meals and snacks being provided at
regular intervals throughout the day. Such a balanced
interplay between exercise and nutrition is generally effective
for preventing exercise-induced hypoglycaemia.
In conclusion, a single session of resistance- or endurance-
type exercise substantially reduces the prevalence of hyper-
glycaemia and improves glycaemic control during the
subsequent 24 h period in individuals with IGT, and in
insulin-treated and non-insulin-treated type 2 diabetic
patients. Given the equal impact of both types of exercise on
daily glycaemic control, endurance-type exercise sessions can
be exchanged for resistance-type exercise sessions without
abating the positive impact of exercise on glycaemic control.
Consequently, a more personalised exercise prescription,
tailored to the needs and capabilities of the individual type 2
diabetic patient, is feasible.
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